Literature DB >> 27425408

An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway.

Thomas P Garner1, Denis E Reyna1, Amit Priyadarshi1, Hui-Chen Chen2, Sheng Li3, Yang Wu1, Yogesh Tengarai Ganesan2, Vladimir N Malashkevich4, Emily H Cheng2, Evripidis Gavathiotis5.   

Abstract

Pro-apoptotic BAX is a cell fate regulator playing an important role in cellular homeostasis and pathological cell death. BAX is predominantly localized in the cytosol, where it has a quiescent monomer conformation. Following a pro-apoptotic trigger, cytosolic BAX is activated and translocates to the mitochondria to initiate mitochondrial dysfunction and apoptosis. Here, cellular, biochemical, and structural data unexpectedly demonstrate that cytosolic BAX also has an inactive dimer conformation that regulates its activation. The full-length crystal structure of the inactive BAX dimer revealed an asymmetric interaction consistent with inhibition of the N-terminal conformational change of one protomer and the displacement of the C-terminal helix α9 of the second protomer. This autoinhibited BAX dimer dissociates to BAX monomers before BAX can be activated. Our data support a model whereby the degree of apoptosis induction is regulated by the conformation of cytosolic BAX and identify an unprecedented mechanism of cytosolic BAX inhibition.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27425408      PMCID: PMC4975667          DOI: 10.1016/j.molcel.2016.06.010

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  45 in total

1.  Conformation of the Bax C-terminus regulates subcellular location and cell death.

Authors:  A Nechushtan; C L Smith; Y T Hsu; R J Youle
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Structure of Bax: coregulation of dimer formation and intracellular localization.

Authors:  M Suzuki; R J Youle; N Tjandra
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

3.  Crystal structure of a BCL-W domain-swapped dimer: implications for the function of BCL-2 family proteins.

Authors:  Erinna F Lee; Grant Dewson; Brian J Smith; Marco Evangelista; Anne Pettikiriarachchi; Con Dogovski; Matthew A Perugini; Peter M Colman; W Douglas Fairlie
Journal:  Structure       Date:  2011-10-12       Impact factor: 5.006

4.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

5.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

6.  Direct and selective small-molecule activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Joseph A Bellairs; Elizaveta S Leshchiner; Loren D Walensky
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

7.  Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers.

Authors:  Seon-Yong Jeong; Brigitte Gaume; Yang-Ja Lee; Yi-Te Hsu; Seung-Wook Ryu; Soo-Han Yoon; Richard J Youle
Journal:  EMBO J       Date:  2004-05-06       Impact factor: 11.598

8.  Movement of Bax from the cytosol to mitochondria during apoptosis.

Authors:  K G Wolter; Y T Hsu; C L Smith; A Nechushtan; X G Xi; R J Youle
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

9.  Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.

Authors:  S Desagher; A Osen-Sand; A Nichols; R Eskes; S Montessuit; S Lauper; K Maundrell; B Antonsson; J C Martinou
Journal:  J Cell Biol       Date:  1999-03-08       Impact factor: 10.539

10.  Regulated targeting of BAX to mitochondria.

Authors:  I S Goping; A Gross; J N Lavoie; M Nguyen; R Jemmerson; K Roth; S J Korsmeyer; G C Shore
Journal:  J Cell Biol       Date:  1998-10-05       Impact factor: 10.539

View more
  26 in total

1.  Isolation of Synthetic Antibodies Against BCL-2-Associated X Protein (BAX).

Authors:  Zhou Dai; Jonathan R Lai
Journal:  Methods Mol Biol       Date:  2019

Review 2.  Progress in targeting the BCL-2 family of proteins.

Authors:  Thomas P Garner; Andrea Lopez; Denis E Reyna; Adam Z Spitz; Evripidis Gavathiotis
Journal:  Curr Opin Chem Biol       Date:  2017-08-17       Impact factor: 8.822

3.  SNAP23 regulates BAX-dependent adipocyte programmed cell death independently of canonical macroautophagy.

Authors:  Daorong Feng; Dulguun Amgalan; Rajat Singh; Jianwen Wei; Jennifer Wen; Tszki Peter Wei; Timothy E McGraw; Richard N Kitsis; Jeffrey E Pessin
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

4.  Cheating Death: New Molecules Block BAX.

Authors:  Loren D Walensky
Journal:  Trends Mol Med       Date:  2019-03-06       Impact factor: 11.951

Review 5.  Physiological and pharmacological modulation of BAX.

Authors:  Adam Z Spitz; Evripidis Gavathiotis
Journal:  Trends Pharmacol Sci       Date:  2021-11-27       Impact factor: 14.819

6.  BH3-Dependent and Independent Activation of BAX and BAK in Mitochondrial Apoptosis.

Authors:  Paul S Jeng; Akane Inoue-Yamauchi; James J Hsieh; Emily H Cheng
Journal:  Curr Opin Physiol       Date:  2018-03-20

7.  Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia.

Authors:  Denis E Reyna; Thomas P Garner; Andrea Lopez; Felix Kopp; Gaurav S Choudhary; Ashwin Sridharan; Swathi-Rao Narayanagari; Kelly Mitchell; Baoxia Dong; Boris A Bartholdy; Loren D Walensky; Amit Verma; Ulrich Steidl; Evripidis Gavathiotis
Journal:  Cancer Cell       Date:  2017-10-09       Impact factor: 31.743

Review 8.  BAX, BAK, and BOK: A Coming of Age for the BCL-2 Family Effector Proteins.

Authors:  Tudor Moldoveanu; Peter E Czabotar
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

Review 9.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Stuart A Aaronson; John M Abrams; Dieter Adam; Patrizia Agostinis; Emad S Alnemri; Lucia Altucci; Ivano Amelio; David W Andrews; Margherita Annicchiarico-Petruzzelli; Alexey V Antonov; Eli Arama; Eric H Baehrecke; Nickolai A Barlev; Nicolas G Bazan; Francesca Bernassola; Mathieu J M Bertrand; Katiuscia Bianchi; Mikhail V Blagosklonny; Klas Blomgren; Christoph Borner; Patricia Boya; Catherine Brenner; Michelangelo Campanella; Eleonora Candi; Didac Carmona-Gutierrez; Francesco Cecconi; Francis K-M Chan; Navdeep S Chandel; Emily H Cheng; Jerry E Chipuk; John A Cidlowski; Aaron Ciechanover; Gerald M Cohen; Marcus Conrad; Juan R Cubillos-Ruiz; Peter E Czabotar; Vincenzo D'Angiolella; Ted M Dawson; Valina L Dawson; Vincenzo De Laurenzi; Ruggero De Maria; Klaus-Michael Debatin; Ralph J DeBerardinis; Mohanish Deshmukh; Nicola Di Daniele; Francesco Di Virgilio; Vishva M Dixit; Scott J Dixon; Colin S Duckett; Brian D Dynlacht; Wafik S El-Deiry; John W Elrod; Gian Maria Fimia; Simone Fulda; Ana J García-Sáez; Abhishek D Garg; Carmen Garrido; Evripidis Gavathiotis; Pierre Golstein; Eyal Gottlieb; Douglas R Green; Lloyd A Greene; Hinrich Gronemeyer; Atan Gross; Gyorgy Hajnoczky; J Marie Hardwick; Isaac S Harris; Michael O Hengartner; Claudio Hetz; Hidenori Ichijo; Marja Jäättelä; Bertrand Joseph; Philipp J Jost; Philippe P Juin; William J Kaiser; Michael Karin; Thomas Kaufmann; Oliver Kepp; Adi Kimchi; Richard N Kitsis; Daniel J Klionsky; Richard A Knight; Sharad Kumar; Sam W Lee; John J Lemasters; Beth Levine; Andreas Linkermann; Stuart A Lipton; Richard A Lockshin; Carlos López-Otín; Scott W Lowe; Tom Luedde; Enrico Lugli; Marion MacFarlane; Frank Madeo; Michal Malewicz; Walter Malorni; Gwenola Manic; Jean-Christophe Marine; Seamus J Martin; Jean-Claude Martinou; Jan Paul Medema; Patrick Mehlen; Pascal Meier; Sonia Melino; Edward A Miao; Jeffery D Molkentin; Ute M Moll; Cristina Muñoz-Pinedo; Shigekazu Nagata; Gabriel Nuñez; Andrew Oberst; Moshe Oren; Michael Overholtzer; Michele Pagano; Theocharis Panaretakis; Manolis Pasparakis; Josef M Penninger; David M Pereira; Shazib Pervaiz; Marcus E Peter; Mauro Piacentini; Paolo Pinton; Jochen H M Prehn; Hamsa Puthalakath; Gabriel A Rabinovich; Markus Rehm; Rosario Rizzuto; Cecilia M P Rodrigues; David C Rubinsztein; Thomas Rudel; Kevin M Ryan; Emre Sayan; Luca Scorrano; Feng Shao; Yufang Shi; John Silke; Hans-Uwe Simon; Antonella Sistigu; Brent R Stockwell; Andreas Strasser; Gyorgy Szabadkai; Stephen W G Tait; Daolin Tang; Nektarios Tavernarakis; Andrew Thorburn; Yoshihide Tsujimoto; Boris Turk; Tom Vanden Berghe; Peter Vandenabeele; Matthew G Vander Heiden; Andreas Villunger; Herbert W Virgin; Karen H Vousden; Domagoj Vucic; Erwin F Wagner; Henning Walczak; David Wallach; Ying Wang; James A Wells; Will Wood; Junying Yuan; Zahra Zakeri; Boris Zhivotovsky; Laurence Zitvogel; Gerry Melino; Guido Kroemer
Journal:  Cell Death Differ       Date:  2018-01-23       Impact factor: 12.067

10.  Huang-Pu-Tong-Qiao Formula Ameliorates the Hippocampus Apoptosis in Diabetic Cognitive Dysfunction Mice by Activating CREB/BDNF/TrkB Signaling Pathway.

Authors:  Shu Ye; Dao-Jun Xie; Peng Zhou; Hua-Wu Gao; Meng-Ting Zhang; Da-Bao Chen; Yun-Peng Qin; Xin Lei; Xin-Quan Li; Juan Liu; Ya-Xun Cheng; Yong-Chuan Yao; Biao Cai; Guo-Ming Shen
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.